Peter Scott Chin sold $37k of DNLI
Chief Medical Officer at Denali Therapeutics Inc.. 1,654 shares at an average of $22.29, traded Sep 4, 2026, filed Sep 9, 2026.
Score components
- +15RoleOfficer
- +6Trade size$37k at market
- 0Share of holdings soldSold 0.8% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002124755-26-000007, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | SOpen-market sale Common Stock | -1,654 | $22.29 | $37k | 204,538 | 33 d ago |
Related signals
Other insiders at Denali Therapeutics Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | Denali Therapeutics Inc. | Nancy Thornberry director | $262k 11,439 shares | -37% | |
| 18Weak | Denali Therapeutics Inc. | Alexander O. Schuth COFO and Secretary | $65k 2,768 shares | -1% | |
| 10Weak | Denali Therapeutics Inc. | Carole Ho Chief Medical Officer | $52k 3,743 shares | -2% | |
| 29Weak | Denali Therapeutics Inc. | Alexander O. Schuth COFO and Secretary | $40k 2,937 shares | -1% | |
| 35Weak | Denali Therapeutics Inc. | Ryan J. Watts President and CEO | $7.4M 495,282 shares | -66% | |
| 43Moderate | Denali Therapeutics Inc. | Steve E. Krognes director | $69k 3,339 shares | -11% | |
| 67Notable | Denali Therapeutics Inc. | Ryan J. Watts President and CEO | $751k 36,916 shares | -13% | |
| 44Moderate | Denali Therapeutics Inc. | Alexander O. Schuth COFO and Secretary | $308k 15,162 shares | -6% | |
| 44Moderate | Denali Therapeutics Inc. | Carole Ho Chief Medical Officer | $308k 15,162 shares | -8% | |
| 18Weak | Denali Therapeutics Inc. | Vicki L Sato director | $64k 3,080 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.